Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Hey Roger and management!

<< Previous

Bullboard Posts

Next >>

Comment by DJDawgon Sep 16, 2024 12:33pm

228 Views

Post# 36225645

RE:RE:Hey Roger and management!

One important point about the whole pre-BTD and BTD timelines is that it was never RDW's or TLT's decision. This kind of thing has to wait on your paid FDA consultant (usually ex-FDA staff themselves) reading the documents from before and looking at the details now and then advising. TLT has many management shortcomings including the way they "predict" BTD timelines. Behind the scenes it would always depend on your consultant saying "yes, you are ready".

So if everything looking imminent, it is because the consultant has given the thumbs up. Not RDW or anyone else.

IMO

<< Previous

Bullboard Posts

Next >>

Advancing flagship Ishkõday Gold Project in Ontario